Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2012

01-09-2012 | Clinical Study

Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival

Authors: Farkhad Manapov, Sabine Klöcking, Maximilian Niyazi, Victor Levitskiy, Claus Belka, Guido Hildebrandt, Rainer Fietkau, Gunther Klautke

Published in: Journal of Neuro-Oncology | Issue 2/2012

Login to get access

Abstract

The brain represents a crucial site of failure in limited-disease (LD) small-cell lung cancer (SCLC). However, no data about correlation between response of primary tumor to chemoradiotherapy (CRT) and brain metastases (BM)–free survival time in LD SCLC are available. A total of 125 LD SCLC patients with initial performance score of WHO 2–3 were successfully treated with CRT. Prophylactic cranial irradiation (PCI) was applied after complete response. Cranial MRI was performed in patients at initial diagnosis, in complete responders before PCI, and by individual symptoms. A total of 30 patients (24 %) developed BM after CRT; 5 of them (17 %) developed BMs after PCI. Ten patients (33 %) show BM after complete, 5 (17 %) after partial and 15 (50 %) after non-response of primary tumor (p < 0.0001) to applied CRT. BM-free survival time for the entire cohort was 298 days (95 CI: 218–377): 567 days (95 CI: 322–811) in complete, 298 days (95 CI: 244–351) in partial and 252 days (95 CI: 217–286) in non-responders (p < 0.0001). PCI prolonged BM-free survival time in complete responders: 640 days (95 CI: 483–796) with PCI versus 482 days (95CI: 111–926) without PCI (p = 0.047) versus 273 days (95 CI: 243–302) for partial and non-responders. The duration of BM-free survival was shown to correlate with long-term outcome in the Pearson and Spearman’s tests (p < 0.0001). The response of primary tumor to CRT strongly affects duration of BM-free survival in LD SCLC and should be considered by planning of the timing of PCI.
Literature
1.
go back to reference Jackman DM, Johnson BE (2005) Small-cell lung cancer. Lancet 367:474 Jackman DM, Johnson BE (2005) Small-cell lung cancer. Lancet 367:474
2.
go back to reference Socinski MA, Bogart JA (2007) Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol 25:4137–4145PubMedCrossRef Socinski MA, Bogart JA (2007) Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol 25:4137–4145PubMedCrossRef
3.
go back to reference Fried DB, Morris DE, Poole C, Rosenman JG, Halle JS, Detterbeck FC, Hensing TA, Socinski MA (2004) Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22:4837–4845PubMedCrossRef Fried DB, Morris DE, Poole C, Rosenman JG, Halle JS, Detterbeck FC, Hensing TA, Socinski MA (2004) Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22:4837–4845PubMedCrossRef
4.
go back to reference Pijls-Johannesma MCG, De Ruysscher D, Lambin P, Rutten I, Vansteenkiste JF (2005) Early versus late chest radiotherapy for limited stage small-cell lung cancer. Cochrane Database Syst Rev 25:CD004700 Pijls-Johannesma MCG, De Ruysscher D, Lambin P, Rutten I, Vansteenkiste JF (2005) Early versus late chest radiotherapy for limited stage small-cell lung cancer. Cochrane Database Syst Rev 25:CD004700
5.
go back to reference De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P (2006) Systematic review and meta-analysis of randomized, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 17:543–552PubMedCrossRef De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P (2006) Systematic review and meta-analysis of randomized, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 17:543–552PubMedCrossRef
6.
go back to reference Komaki R, Cox JD, Whitson W (1981) Risk of brain metastasis in small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65:811–814PubMed Komaki R, Cox JD, Whitson W (1981) Risk of brain metastasis in small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65:811–814PubMed
7.
go back to reference Seute T, Leffers P, ten Velde GPM, Twijnstra A (2008) Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer 112:1827–1834PubMedCrossRef Seute T, Leffers P, ten Velde GPM, Twijnstra A (2008) Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer 112:1827–1834PubMedCrossRef
8.
go back to reference Hirsch FR, Paulson OB, Hansen HH, Vraa-Jensen J (1982) Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer 50:2433–2437PubMedCrossRef Hirsch FR, Paulson OB, Hansen HH, Vraa-Jensen J (1982) Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer 50:2433–2437PubMedCrossRef
9.
go back to reference Postmus PE, Haaxma-Reiche H, Smit EF, Groen HJ, Karnicka H, Lewinski T, van Meerbeeck J, Clerico M, Gregor A, Curran D, Sahmoud T, Kirkpatrick A, Giaccone G (2000) Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy—a phase III Study of the European Organisation for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18:3400–3408PubMed Postmus PE, Haaxma-Reiche H, Smit EF, Groen HJ, Karnicka H, Lewinski T, van Meerbeeck J, Clerico M, Gregor A, Curran D, Sahmoud T, Kirkpatrick A, Giaccone G (2000) Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy—a phase III Study of the European Organisation for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18:3400–3408PubMed
10.
go back to reference Kouvaris JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous XN, Vlahos LJ (2007) Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30:361–366PubMedCrossRef Kouvaris JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous XN, Vlahos LJ (2007) Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30:361–366PubMedCrossRef
11.
go back to reference Manapov F (2009) Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy. J Neurooncol 98:349–355PubMedCrossRef Manapov F (2009) Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy. J Neurooncol 98:349–355PubMedCrossRef
12.
go back to reference Mira JG, Chen TT, Livingston RB, Wilson HE (1988) Outcome of prophylactic and therapeutic cranial irradiation in disseminated small cell lung carcinoma: a Southwest Oncology Group Study. Int J Radiat Oncol Biol Phys 14:861–865PubMedCrossRef Mira JG, Chen TT, Livingston RB, Wilson HE (1988) Outcome of prophylactic and therapeutic cranial irradiation in disseminated small cell lung carcinoma: a Southwest Oncology Group Study. Int J Radiat Oncol Biol Phys 14:861–865PubMedCrossRef
13.
go back to reference Auperin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 12:476–484CrossRef Auperin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 12:476–484CrossRef
14.
go back to reference Slotman BJ, Faivre-Finn C, Kramer GW, Rankin E, Snee M, Hatton M, Postmus PE, Collette L, Musat E, Senan S (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Eng J Med 16;357:664–672 Slotman BJ, Faivre-Finn C, Kramer GW, Rankin E, Snee M, Hatton M, Postmus PE, Collette L, Musat E, Senan S (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Eng J Med 16;357:664–672
15.
go back to reference Baas P, Belderbos JS, Senan S, Kwa HB, van Bochove A, van Tinteren H, Burgers JA, van Meerbeeck JP (2006) Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutsch multicenter phase II study. Br J Cancer 13:625–630 Baas P, Belderbos JS, Senan S, Kwa HB, van Bochove A, van Tinteren H, Burgers JA, van Meerbeeck JP (2006) Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutsch multicenter phase II study. Br J Cancer 13:625–630
16.
go back to reference van de Velde H, Bosquee L, Weynants P, Canon JL, Rosier JF, Humblet Y (1999) Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Ann Oncol 10:1051–1057PubMedCrossRef van de Velde H, Bosquee L, Weynants P, Canon JL, Rosier JF, Humblet Y (1999) Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Ann Oncol 10:1051–1057PubMedCrossRef
17.
go back to reference Manapov F, Klautke G, Fietkau R (2008) Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol 3:652–655PubMedCrossRef Manapov F, Klautke G, Fietkau R (2008) Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol 3:652–655PubMedCrossRef
18.
go back to reference van Oosterhout AG, van de Pol M, ten Velde GP, Twijnstra A (1996) Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 77:1434–1441PubMedCrossRef van Oosterhout AG, van de Pol M, ten Velde GP, Twijnstra A (1996) Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 77:1434–1441PubMedCrossRef
19.
go back to reference Sculier JP, Feld R, Evans WK, DeBoer G, Shepherd FA, Payne DG, Pringle JF, Yeoh JL, Quirt IC, Curtis JE (1987) Neurologic disorders in patients with small cell lung cancer. Cancer 60:2275–2283PubMedCrossRef Sculier JP, Feld R, Evans WK, DeBoer G, Shepherd FA, Payne DG, Pringle JF, Yeoh JL, Quirt IC, Curtis JE (1987) Neurologic disorders in patients with small cell lung cancer. Cancer 60:2275–2283PubMedCrossRef
20.
go back to reference Stiess J, Kiricuta IC, Mueller G, Bohndorf W (1995) Usefulness of prophylactic whole brain irradiation in small-cell bronchial carcinoma. Strahlenther Onkol 171:284–289PubMed Stiess J, Kiricuta IC, Mueller G, Bohndorf W (1995) Usefulness of prophylactic whole brain irradiation in small-cell bronchial carcinoma. Strahlenther Onkol 171:284–289PubMed
21.
go back to reference Lee JS, Umsawasdi T, Barkley HT Jr, Lee JS, Chiuten DF, Dhingra HM, Murphy WK, Smith TL, Welch S, Valdivieso M (1987) Timing of elective brain irradiation: a critical factor for brain-metastasis-free survival in small cell lung cancer. Int J Radiat Oncol Biol Phys 13:697–704PubMedCrossRef Lee JS, Umsawasdi T, Barkley HT Jr, Lee JS, Chiuten DF, Dhingra HM, Murphy WK, Smith TL, Welch S, Valdivieso M (1987) Timing of elective brain irradiation: a critical factor for brain-metastasis-free survival in small cell lung cancer. Int J Radiat Oncol Biol Phys 13:697–704PubMedCrossRef
22.
go back to reference Ichinose Y, Hara N, Ohta M, Motohiro A, Hata K, Yagawa K (1989) Brain metastases in patients with limited small cell lung cancer achieving complete remission: correlation with TNM staging. Chest 96:1332–1335PubMedCrossRef Ichinose Y, Hara N, Ohta M, Motohiro A, Hata K, Yagawa K (1989) Brain metastases in patients with limited small cell lung cancer achieving complete remission: correlation with TNM staging. Chest 96:1332–1335PubMedCrossRef
23.
go back to reference Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216PubMedCrossRef Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216PubMedCrossRef
24.
go back to reference Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C (1987) Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Eng J Med 316:912–918CrossRef Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C (1987) Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Eng J Med 316:912–918CrossRef
25.
go back to reference Perry MC, Herndon JE III, Eaton WL, Green MR (1998) Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. J Clin Oncol 16:2466–2467PubMed Perry MC, Herndon JE III, Eaton WL, Green MR (1998) Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. J Clin Oncol 16:2466–2467PubMed
26.
go back to reference Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, Payne D, Kostashuk EC, Evans WK, Dixon P (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small-cell lung cancer. J Clin Oncol 11:336–344PubMed Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, Payne D, Kostashuk EC, Evans WK, Dixon P (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small-cell lung cancer. J Clin Oncol 11:336–344PubMed
27.
go back to reference Coy P, Hodson DI, Murray N, Pater JL, Payne DG, Arnold A, Kostashuk E, Dixon P, Evans WK, Zee B (1994) Pattern of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 28:355–362PubMedCrossRef Coy P, Hodson DI, Murray N, Pater JL, Payne DG, Arnold A, Kostashuk E, Dixon P, Evans WK, Zee B (1994) Pattern of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 28:355–362PubMedCrossRef
28.
go back to reference Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small cell lung cancer. J Clin Oncol 15:893–900PubMed Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1997) Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small cell lung cancer. J Clin Oncol 15:893–900PubMed
29.
go back to reference Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054–3060PubMedCrossRef Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054–3060PubMedCrossRef
30.
go back to reference Seute T, Leffers P, ten Velde GP, Twijnstra A (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100:801–806PubMedCrossRef Seute T, Leffers P, ten Velde GP, Twijnstra A (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100:801–806PubMedCrossRef
31.
go back to reference Giuliani M, Sun A, Bezjak A, Ma C, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ (2010) Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. Cancer 116:5694–5699PubMedCrossRef Giuliani M, Sun A, Bezjak A, Ma C, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ (2010) Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. Cancer 116:5694–5699PubMedCrossRef
32.
go back to reference Suwinski R, Lee SP, Withers HR (1998) Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 40:797–806PubMedCrossRef Suwinski R, Lee SP, Withers HR (1998) Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 40:797–806PubMedCrossRef
Metadata
Title
Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival
Authors
Farkhad Manapov
Sabine Klöcking
Maximilian Niyazi
Victor Levitskiy
Claus Belka
Guido Hildebrandt
Rainer Fietkau
Gunther Klautke
Publication date
01-09-2012
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2012
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-0894-4

Other articles of this Issue 2/2012

Journal of Neuro-Oncology 2/2012 Go to the issue